Abbott reaches agreements to resolve portion of specialty-formula litigation
Abbott says it has reached agreements to resolve a portion of litigation involving its specialty formulas for preterm infants, with no terms disclosed in the alert.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Abbott says it has reached agreements to resolve a portion of litigation involving its specialty formulas for preterm infants, with no terms disclosed in the alert.
Abbott says it has reached agreements to resolve a portion of litigation involving its Specialty formulas for preterm infants.